A detailed history of Kearns & Associates LLC transactions in Stryker Corp stock. As of the latest transaction made, Kearns & Associates LLC holds 960 shares of SYK stock, worth $369,456. This represents 0.23% of its overall portfolio holdings.

Number of Shares
960
Previous 960 -0.0%
Holding current value
$369,456
Previous $326,000 6.13%
% of portfolio
0.23%
Previous 0.24%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

BUY
$205.51 - $253.93 $197,289 - $243,772
960 New
960 $0

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Kearns & Associates LLC Portfolio

Follow Kearns & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kearns & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kearns & Associates LLC with notifications on news.